US equities |
META $630.56 ▲+0.00% MU $903.70 ▲+0.00% TSLA $391.62 ▲+0.00% NVDA $216.00 ▲+0.00% SPCX $146.90 ▲+0.00% SNDK $1,255.58 ▲+0.00% INTC $90.47 ▲+0.00% SKHY $142.62 ▲+0.00%
FinancialContent

Thermo Fisher Scientific (NY:TMO)

684.89 UNCHANGED
Delayed Quote Updated: 7:00 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
News headline image
3 healthcare stocks we keep off our radar
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva... 
Via StockStory
News headline image
TMO Q3 deep dive: pharma demand, AI integration, and end-market recovery drive momentum
Life sciences company Thermo Fisher (NYSE:TMO) reported Q3 2026 results beating Wall Street’s revenue expectations, with sales up 9.1% year on year to $12.14... 
Via StockStory
Topics Artificial Intelligence
News headline image
Thermo Fisher Scientific: 3 Key Takeaways for Long-Term Investors ↗
Strategic acquisitions are deepening customer relationships while AI integration boosts lab productivity, positioning the company for durable margin expansion. 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
Thermo Fisher (TMO) Q3 2026 Earnings Call Transcript ↗
Adjusted EPS surged 15% as revenue hit $12.14 billion. 
Via The Motley Fool
Topics Earnings
Thermo Fisher Scientific (NYSE:TMO) Posts Q3 Earnings Beat With In-Line Revenue ↗
Via Chartmill
Topics Earnings
News headline image
Thermo Fisher Scientific Q3 Earnings Call Highlights ↗
Thermo Fisher Scientific (NYSE:TMO) reported third-quarter revenue growth of 9% to $12.14 billion, supported by 6% organic growth, acquisitions and foreign-exchange effects. Adjusted earnings per share... 
Via MarketBeat
Topics Artificial Intelligence Earnings World Trade
S&P 500 Premarket Movers on Oct. 21: Tech Hardware and AI Suppliers Gain, Health Care Declines ↗
Via Chartmill
Topics Artificial Intelligence Stocks Supply Chain
News headline image
Thermo Fisher (NYSE:TMO) Exceeds Q3 2026 Expectations
Life sciences company Thermo Fisher (NYSE:TMO) reported Q3 2026 results beating Wall Street’s revenue expectations, with sales up 9.1% year on year to $12.14... 
Via StockStory
News headline image
Thermo Fisher Scientific Reports Third Quarter 2026 Results
From Thermo Fisher Scientific Inc.
Via Business Wire
Thermo Fisher Scientific (NYSE:TMO) Shows Strong Technical Breakout Setup ↗
Via Chartmill
News headline image
Thermo Fisher (TMO) Reports Earnings Tomorrow: What To Expect
Life sciences company Thermo Fisher (NYSE:TMO) will be reporting results this Wednesday before the bell. Here’s what investors should know. Thermo Fisher bea... 
Via StockStory
News headline image
Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built ↗
Biotech stocks trade on FDA trial phases. Phase 2 data often builds value, cash runway limits dilution, and Quantum BioPharma just began a phase 2 MS trial. 
Via MarketBeat
Topics Artificial Intelligence
Which S&P500 stocks are gapping on Thursday? ↗
Via Chartmill
News headline image
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
3 Reasons to Sell TMO and 1 Stock to Buy Instead
Thermo Fisher’s 36.4% return over the past six months has outpaced the S&P 500 by 20.1%, and its stock price has climbed to $652.30 per share. This was partl... 
Via StockStory
Topics Stocks
News headline image
Thermo Fisher Sees Stronger Demand, Calls 2026 an ‘Outstanding Year’ ↗
Thermo Fisher Scientific (NYSE:TMO) Chairman and Chief Executive Officer Marc Casper said the company is seeing improving demand across several end markets and expects 2026 to be an “outstanding year,”... 
Via MarketBeat
Topics Artificial Intelligence Initial Public Offering
News headline image
If You Invested $1000 In Thermo Fisher Scientific Stock 15 Years Ago, You Would Have This Much Today ↗
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 15 years by 4.35% on an annualized basis producing an average annual return of 17.57%. Currently, Thermo Fisher Scientific... 
Via Benzinga
News headline image
1 Healthcare Stock for Long-Term Investors and 2 We Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be... 
Via StockStory
News headline image
Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
Here's How Much $1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth Today ↗
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 1.87% on an annualized basis producing an average annual return of 15.26%. Currently, Thermo Fisher Scientific... 
Via Benzinga
News headline image
3 Unpopular Stocks We Find Risky
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t... 
Via StockStory
Topics Artificial Intelligence
News headline image
Q2 Earnings Highs And Lows: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how research tools & consu... 
Via StockStory
Topics Economy
News headline image
3 S&P 500 Stocks with Open Questions
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch... 
Via StockStory
Topics Stocks
News headline image
3 Profitable Stocks We’re Skeptical Of
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
$1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today ↗
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 1.15% on an annualized basis producing an average annual return of 14.61%. Currently, Thermo Fisher Scientific... 
Via Benzinga
News headline image
3 Cash-Producing Stocks We Think Twice About
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
The Top 5 Analyst Questions From Thermo Fisher’s Q2 Earnings Call
Thermo Fisher’s second quarter saw a notable uptick in end-market activity, propelling results above Wall Street’s expectations and leading to a positive mar... 
Via StockStory
Topics Earnings
News headline image
TMO Q2 Deep Dive: Broad-Based End Market Growth and Strategic Portfolio Moves
Life sciences company Thermo Fisher (NYSE:TMO) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 10.5% year on year to $11.... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >